Registration

FEDERAL HEALTH POLICY STRATEGIES for HUMACYTE

Firm
Client
Income
—
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Access to and reimbursement for innovative regenerative medicine therapies

LobbyistCovered position, as disclosed
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee

Health Issues HCR

Access to and reimbursement for innovative regenerative medicine therapies

LobbyistCovered position, as disclosed
COLIN ROSKEY New Health Policy Advisor and Counsel, Senate Finance Committee

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.